AARTIDRUGSNSEAarti Drugs Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 3 Feb, 2026 · 19:33 IST

Aarti Drugs Q3 FY26: Rs 91 cr PAT, Rs 2 interim dividend

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-6.0%Reaction day
₹393.40
prior close
₹356.30
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%-7.3% vs market
Pharmaceuticals peers, median of 155sector+0.2%-6.2% vs sector

On the reaction day the stock moved 7.3 pts less than Nifty Microcap 250 and 6.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.7
10m
+1.9
15m
+2.0
30m
+2.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-6.0+1.3-7.3+0.2-6.2
Next day
-4.5+0.3-4.8-0.4-4.2
2d
-4.7-0.5-4.2-1.1-3.6
3d
-4.3+2.1-6.4+0.7-5.0
4d
-4.1+3.1-7.2+1.3-5.4
5d
-4.7+2.6-7.3+1.5-6.1
1w
-5.7+0.6-6.2+0.3-6.0
15d
-5.8-1.4-4.4-2.3-3.6
1m
-8.4-6.9-1.5-5.1-3.3
2m
-9.6-7.7-1.9-7.9-1.7
3m
+0.7+7.0-6.3+0.8-0.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs posted Q3 FY26 standalone revenue of Rs 601.71 cr versus Rs 555.6 cr YoY, with profit after tax of Rs 91.27 cr. Nine-month PAT was Rs 140.54 cr. Board declared Rs 2 per share interim dividend (20%) with Feb 9, 2026 as record date. New Sayakha Gujarat plant began commercial operations in September 2025. Three senior managers were added to the Senior Management Personnel list.

Likely market impact

Strong Q3 earnings growth and dividend declaration are positive for shareholders. New plant supports revenue growth; watch margin trends.